Local radiotherapy for pleural dissemination of thymic tumors after initial treatment.


Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
10 Jul 2021
Historique:
received: 11 01 2021
revised: 13 03 2021
accepted: 28 04 2021
pubmed: 27 5 2021
medline: 24 12 2021
entrez: 26 5 2021
Statut: ppublish

Résumé

Pleural dissemination is a common pattern of failure after initial treatment of thymoma and thymic carcinoma, but there is no standardized treatment. As these tumors are relatively radiosensitive, we investigated the effectiveness of radiotherapy. Twenty patients underwent 33 series of local radiotherapy for 96 pleural dissemination lesions after initial treatment. Conventional radiotherapy (CRT), tomotherapy, and combination of the two were employed in 19, 13, and 1 series, respectively. The median follow-up period after the first irradiation for pleural dissemination was 46 months (range, 14-161). For all 20 patients, overall survival (OS) rates from initial radiotherapy for pleural dissemination were 100% at three years and 86% at five years. Progression-free survival (PFS) rates after 33 series of radiotherapy were 30% at three years and 16% at five years. Local control (LC) rates for 96 lesions were 98% at three years and 96% at five years. In-field recurrence was observed in only two among the 96 lesions. One patient (5%) developed grade 3 radiation pneumonitis and another (5%) developed grade 3 pericardial effusion. No other serious adverse events were observed. When disseminated nodules can be covered within localized fields, local radiotherapy may be a treatment option. Using tomotherapy, multiple lesions can be treated safely.

Identifiants

pubmed: 34036359
pii: 6283624
doi: 10.1093/jrr/rrab046
pmc: PMC8273798
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

676-681

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Références

Ann Thorac Surg. 2010 Mar;89(3):912-7
pubmed: 20172153
Am J Clin Oncol. 2006 Aug;29(4):336-44
pubmed: 16891859
J Thorac Cardiovasc Surg. 1997 Jan;113(1):55-63
pubmed: 9011702
Ann Thorac Surg. 2011 Dec;92(6):1984-91; discussion 1991-2
pubmed: 22115206
Ann Thorac Surg. 1991 Jan;51(1):152-6
pubmed: 1985561
Radiother Oncol. 2007 Jul;84(1):52-5
pubmed: 17532496
Radiother Oncol. 1992 Aug;24(4):221-5
pubmed: 1410577
World J Surg. 2009 Jul;33(7):1425-31
pubmed: 19424745
Ann Thorac Surg. 2005 May;79(5):e32-3
pubmed: 15854916
J Clin Oncol. 2016 Aug 10;34(23):2761-8
pubmed: 27325859
J Clin Oncol. 1994 Jun;12(6):1164-8
pubmed: 8201378
Cancer. 1987 Dec 1;60(11):2727-43
pubmed: 3677008
Radiat Med. 1997 Nov-Dec;15(6):399-403
pubmed: 9495791
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818799355
pubmed: 30222523
J Thorac Oncol. 2014 Jul;9(7):1018-1022
pubmed: 24926546
J Thorac Oncol. 2014 Dec;9(12):1796-804
pubmed: 25393792
Eur J Radiol. 2018 Jun;103:38-43
pubmed: 29803383
Chest. 2002 Feb;121(2):480-7
pubmed: 11834661
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1278-83
pubmed: 22607910
J Radiat Res. 2016 Aug;57 Suppl 1:i76-i82
pubmed: 27006380
J Thorac Oncol. 2014 Mar;9(3):403-9
pubmed: 24518091
J Thorac Oncol. 2008 Jan;3(1):75-81
pubmed: 18166844
Ann Thorac Surg. 2010 Jan;89(1):245-52; discussion 252
pubmed: 20103246
J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S260-5
pubmed: 20859116
Ann Surg Oncol. 2019 Jul;26(7):2073-2080
pubmed: 30924019
Pathol Int. 1994 May;44(5):359-67
pubmed: 8044305
Gen Thorac Cardiovasc Surg. 2019 Jun;67(6):524-529
pubmed: 30725276
Surg Case Rep. 2015;1(1):75
pubmed: 26366371
J Thorac Cardiovasc Surg. 1996 Aug;112(2):376-84
pubmed: 8751506
J Thorac Cardiovasc Surg. 2009 May;137(5):1185-9
pubmed: 19379989
J Surg Oncol. 1993 Nov;54(3):180-3
pubmed: 8412175
Ann Thorac Surg. 1997 Dec;64(6):1593-8
pubmed: 9436541
Eur J Intern Med. 2006 Dec;17(8):575-7
pubmed: 17142178

Auteurs

Dai Okazaki (D)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Yuta Shibamoto (Y)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Takeshi Yanagi (T)

Narita Memorial Proton Center, 78 Shirakawa-cho, Toyohashi, Aichi 441-8021, Japan.

Satoshi Ishikura (S)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Takuhito Kondo (T)

Department of Radiology, Nagoya Ekisaikai Hospital, 4-66 Syonen-cyo, Nakagawa-ku, Nagoya, Aichi 454-8502, Japan.

Yuki Yamada (Y)

Department of Radiation Oncology, Kasugai Municipal Hospital, 1-1-1 Takaki-cho, Kasugai, Aichi 486-8510, Japan.

Masanari Niwa (M)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH